Suchergebnisse - "Vallet, Sonia"

PubPharm (49)

1

Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer

enthalten in: Breast cancer research and treatment | 2018

von Vallet, S. | Fan, F. | Malvestiti, S. | +8

2

Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence

enthalten in: Urologic oncology | 2016

von Grüllich, C. | Vallet, S. | Hecht, C. | +5

3

In vitro and in vivo toxicity of 5-FdU-alendronate, a novel cytotoxic bone-seeking duplex drug against bone metastasis

enthalten in: Investigational new drugs | 2015

von Schott, S. | Vallet, S. | Tower, R. | +4

4

Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort

enthalten in: World journal of urology | 2014

von Höfner, T. | Vallet, S. | Hadaschik, B. | +5

5

Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128–350 triggers MM cell death via c-Jun upregulation

enthalten in: Cancer letters | 2014

von Fan, F. | Tonon, G. | Bashari, M. | +9

6

New insights, recent advances, and current challenges in the biological treatment of multiple myeloma

enthalten in: Expert opinion on biological therapy | 2013

von Vallet, S. | Podar, K.

7

In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma

enthalten in: Bone | 2013

von Pozzi, S. | Fulciniti, M. | Yan, H. | +13

8

Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies

enthalten in: Expert opinion on pharmacotherapy | 2012

von Vallet, S. | Witzens-Harig, M. | Jaeger, D. | +1

9

The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications

enthalten in: British journal of haematology | 2011

von Podar, K. | Zimmerhackl, A. | Fulciniti, M. | +10

10

CCR1 as a target for multiple myeloma

enthalten in: Expert opinion on therapeutic targets | 2011

von Vallet, S. | Anderson, K.

1
2
3
4
5
Nächster »
[5]